Home > Balance Sheet > NATCO PHARMA

NATCO PHARMA
Sundry Debtors

    Back to Balance Sheet
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Sundry Debtors History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Sundry Debtors ₹1,189 Cr₹856 Cr₹621 Cr₹413 Cr₹551 Cr

What is the latest Sundry Debtors ratio of NATCO PHARMA ?

The latest Sundry Debtors ratio of NATCO PHARMA is ₹1,189 Cr based on Mar2024 Consolidated results.
Year Sundry Debtors
Mar2024₹1,189 Cr
Mar2023₹856 Cr
Mar2022₹621 Cr
Mar2021₹413 Cr
Mar2020₹551 Cr

How is Sundry Debtors of NATCO PHARMA Trending?

Years Sundry Debtors % Change
Mar2024 ₹1,189 Cr
38.87
Mar2023 ₹856 Cr
37.95
Mar2022 ₹621 Cr
50.30
Mar2021 ₹413 Cr
-25.10
Mar2020 ₹551 Cr -

Compare Sundry Debtors of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹14,499.0 Cr -5.5% 1.5% -21.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,648.0 Cr -4.9% 2.1% 15.5% Stock Analytics
DIVIS LABORATORIES ₹159,310.0 Cr -2.2% 9.3% 50.5% Stock Analytics
CIPLA ₹119,410.0 Cr -4.2% 4.5% 4.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹106,189.0 Cr -4.4% -4.5% 17.2% Stock Analytics
DR REDDYS LABORATORIES ₹96,496.4 Cr -1.4% 4.2% -8.8% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-5.5%

1.5%

-21.2%

SENSEX

-1.3%

4.1%

7.6%


You may also like the below Video Courses